Delivering solutions to the challenges of manufacturing gene and cell therapies has never been so significant, as more products move towards commercialization. The supply chain for these potentially transformative therapies is uniquely complex, making it essential to understand and optimize the various components including standardization and risk mitigation with your outsourcing partners.

In our latest interactive webinar, our panelists will explore standardization techniques for the cell and gene therapy supply chain, addressing issues such as:

• The feasibility of achieving standardization with so many elements to your supply chain logistics;
• How we as an industry can approach standardization;
• Advantages and disadvantages of outsourcing and managing your supplier relationships to minimize risk;
• Key considerations when assessing which elements of your supply chain could or should be outsourced.